Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,938 | 83,517 | 89,352 | 94,430 | 84,802 |
| TOTAL | $79,059 | $86,948 | $92,731 | $97,896 | $86,071 |
| Non-Current Assets | |||||
| PPE Net | 34 | 38 | 42 | 12 | 15 |
| Other Non-Current Assets | 139 | 166 | 193 | 219 | 244 |
| TOTAL | $172 | $204 | $235 | $231 | $259 |
| Total Assets | $79,231 | $87,152 | $92,966 | $98,127 | $86,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,721 | 2,396 | 1,001 | 1,452 | 1,029 |
| Accrued Expenses | 3,196 | 2,045 | 788 | 1,189 | 1,199 |
| TOTAL | $6,036 | $4,555 | $1,900 | $2,748 | $2,332 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21 | 52 | 83 | 112 | 140 |
| TOTAL | $21 | $52 | $83 | $112 | $140 |
| Total Liabilities | $6,057 | $4,608 | $1,983 | $2,861 | $2,472 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,879 | 89,704 | 89,704 | 89,704 | 74,998 |
| Common Shares | 92 | 90 | 90 | 90 | 75 |
| Retained earnings | -117,878 | -108,185 | -99,357 | -94,780 | -91,437 |
| TOTAL | $73,174 | $82,544 | $90,983 | $95,266 | $83,858 |
| Total Liabilities And Equity | $79,231 | $87,152 | $92,966 | $98,127 | $86,330 |